Bukwang Pharm Decides to Acquire and Cancel Treasury Shares Worth 25 Billion KRW
[Asia Economy Reporter Koo Eun-mo] Bukwang Pharmaceutical announced on the 8th that it has decided to acquire 1,916,000 shares of its own stock worth 25,038 million KRW on the market and then cancel them. The scheduled end date for the treasury stock acquisition and the cancellation date is April 7.
Hot Picks Today
"Could I Also Receive 370 Billion Won?"... No Limit on 'Stock Manipulation Whistleblower Rewards' Starting the 26th
- Samsung Electronics Labor-Management Reach Agreement, General Strike Postponed... "Deficit-Business Unit Allocation Deferred for One Year"
- "From a 70 Million Won Loss to a 350 Million Won Profit with Samsung and SK hynix"... 'Stock Jackpot' Grandfather Gains Attention
- "Stocks Are Not Taxed, but Annual Crypto Gains Over 2.5 Million Won to Be Taxed Next Year... Investors Push Back"
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
